Erste Asset Management Gmb H United Therapeutics Corp Transaction History

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

A detailed history of Erste Asset Management Gmb H transactions in United Therapeutics Corp stock. As of the latest transaction made, Erste Asset Management Gmb H holds 42,962 shares of UTHR stock, worth $19.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

42,962

Previous 39,295 9.33%

Holding current value

$19.3 Million

Previous $12.1 Billion 1.35%

% of portfolio

0.1%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$276.47 - $328.4 $1.01 Million - $1.2 Million	3,667 Added 9.33%	42,962 $12.2 Billion
Q1 2025 May 14, 2025	SELL	$304.42 - $380.78 $2.39 Million - $2.99 Million	-7,841 Reduced 16.63%	39,295 $12.1 Billion
Q4 2024 Feb 10, 2025	BUY	$348.66 - $410.0 $651,994 - $766,700	1,870 Added 4.13%	47,136 $17 Billion
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $14.1 Million - $16.5 Million	45,266 New	45,266 $16.2 Billion
Q2 2024 Nov 26, 2024	BUY	$228.26 - $319.04 $136,271 - $190,466	597 Added 1.29%	47,050 $14.9 Billion
Q1 2024 Nov 26, 2024	BUY	$210.76 - $249.51 $772,224 - $914,204	3,664 Added 8.56%	46,453 $11.1 Billion
Q4 2023 Nov 26, 2024	BUY	$214.88 - $256.94 $824,064 - $985,364	3,835 Added 9.84%	42,789 $9.36 Billion
Q3 2023 Nov 26, 2024	BUY	$211.82 - $248.24 $2.02 Million - $2.36 Million	9,513 Added 32.31%	38,954 $8.83 Billion
Q2 2023 Nov 26, 2024	BUY	$205.19 - $232.99 $424,127 - $481,590	2,067 Added 5.79%	37,788 $8.3 Billion
Q1 2023 Nov 26, 2024	BUY	$212.99 - $276.17 $4.46 Million - $5.78 Million	20,946 Added 141.77%	35,721 $7.86 Billion
Q4 2022 Nov 26, 2024	BUY	$205.95 - $280.43 $3.07 Million - $4.18 Million	14,918 Added 102.72%	29,441 $8.14 Billion
Q3 2022 Nov 26, 2024	SELL	$203.3 - $244.17 $6.2 Million - $7.44 Million	-30,491 Reduced 67.36%	14,775 $3.07 Billion
Q2 2022 Nov 26, 2024	BUY	$174.81 - $241.14 $2.54 Million - $3.5 Million	14,523 New	14,523 $3.46 Billion
Q1 2022 Nov 22, 2024	BUY	$166.16 - $213.96 $574,913 - $740,301	3,460 Added 32.95%	13,960 $2.45 Billion
Q4 2021 Nov 22, 2024	SELL	$184.32 - $216.08 $6.07 Million - $7.12 Million	-32,955 Reduced 72.8%	12,311 $2.65 Billion
Q2 2021 Nov 22, 2024	BUY	$170.47 - $211.93 $1.79 Million - $2.23 Million	10,500 New	10,500 $1.86 Billion
Q1 2021 Nov 22, 2024	SELL	$153.94 - $174.85 $0 - $0	0 Closed	0 $0
Q4 2020 Nov 22, 2024	BUY	$101.87 - $151.79 $0 - $0	0 New	0 $0
Q3 2020 Nov 22, 2024	SELL	$99.9 - $121.13 $4.52 Million - $5.48 Million	-45,266 Closed	0 $0
Q2 2020 Nov 22, 2024	SELL	$92.74 - $125.82 $4.2 Million - $5.7 Million	-45,266 Closed	0 $0
Q3 2019 Nov 22, 2024	BUY	$74.85 - $85.99 $0 - $0	0 New	0 $0
Q2 2019 Nov 22, 2024	BUY	$76.06 - $120.81 $0 - $0	0 New	0 $0
Q1 2019 Nov 22, 2024	SELL	$107.15 - $126.84 $4.85 Million - $5.74 Million	-45,266 Closed	0 $0
Q4 2018 Nov 26, 2024	SELL	$101.4 - $128.73 $4.59 Million - $5.83 Million	-45,266 Closed	0 $0

Others Institutions Holding UTHR

# of Institutions

746

Shares Held

44.1M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $20.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H United Therapeutics Corp Transaction History